Numinus Wellness Inc.(TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, reported its financial results late Monday for the three and twelve months ended August 31, 2022.

"Fiscal 2022 was a pivotal year for Numinus, as we entered the US market with the transformational acquisition of Novamind, expanded our Ketamine-assisted Therapy offering across Canada, launched a formal practitioner training program, and unveiled a global rebranding of our company," statedPayton Nyquvest, founder and CEO. "Combined, these efforts have provided a solid platform for our continued, measured growth – with scalable infrastructure and...